Photochemical Rearrangement of a 6-Azasteroid Oxaziridine to a Novel 17β-Carbomethoxy-A-homo-B-seco-6-aza-3, 5-androstanedione
DOI:
https://doi.org/10.29356/jmcs.v53i3.994Keywords:
Azasteroids, 5a-reductase, steroidal heterocycles, photochemistry, synthesis, oxaziridineAbstract
4- and 6-azasteroids have been shown to be potent inhibitors of human 5α-reductase and certain azasteroids have shown significant clinical benefit in the treatment of androgen-related disorders. In an effort to expand the diversity of steroidal heterocycles synthetically accessible for structure-activity relationship exploration, a novel reaction sequence was applied to the preparation of the 6-azasteroid framework. To this end, photolysis of the oxaziridine derived from 17β-carbomethoxy-3β-triisopropylsilyloxy-6-azaandrost-5-ene (1) yielded a novel 7, 5-steroidal ring system that was evaluated for inhibition of human type 1 and 2 5α-reductase.
Downloads
Download data is not yet available.
References
1. Russell, D. W.; Wilson, J. D. Annu. Rev. Biochem. 1994, 63, 2561.
2. (a) Rasmusson, G. H.; Reynolds, G. F.; Steinberg, N. G.; Walton, E.; Patel, G.F.; Liang, T.; Cascieri, M. A.; Cheung, A. H.; Brooks, J. R.; Berman, C. J. Med. Chem. 1986, 29, 2298-2315. (b) Frye, S. V.; Haffner, C. D.; Maloney, P. R.; Mook, R. A.; Jr., Dorsey, G. F.; Jr., Hiner, R. N.; Cribbs, C. M.; Wheeler, T. N.; Ray, J. A.; Andrews, R. C.; Batchelor, K. W.; Bramson, H. N.; Stuart, J. D.; Schweiker, S. L.; Van Arnold, J.; Croom, S.; Bickett, D. M.; Moss, M. L.; Tian, G.; Unwalla, R. J.; Lee, F. W.; Tippin, T. K.; James, M. K.; Long, J. E.; Schuster, S. V. J. Med. Chem. 1994, 37, 2352-2360. (c) Frye, S. V. Current Pharm. Design 1996, 2, 59-84.
3. Pirrung, M. C.; Chen, J.; Rowley, E. G.; McPhail, A. T. J. Am. Chem. Soc. 1993, 115, 7103-7110.
4. (a) Holt, D. A.; Levy, M. A.; Oh, H.-J.; Erb, J. M.; Heaslip, J. I.; Brandt, M.; Lan-Hargest, H.-Y.; Metcalf, B. W. J. Med. Chem. 1990, 33, 943-950. (b) Haffner, C.D. Tetrahedron Lett. 1994, 35, 1349-1353.
5. Lattes, A.; Oliveros, E.; Riviere, M.; Belzecki, C.; Mostowicz, D.; Abramskj, W.; Piccinni-Leopardi, C.; Germain, G.; Meerssche, M. V. J. Am. Chem. Soc. 1982, 104, 3929-3934.
6. (a) Aubé, J.; Wang, Y.; Hammond, M.; Tanol, M.; Takusagawa, F.; Velde, D. V. J. Am. Chem. Soc. 1990, 112, 4879-4891. (b) Aubé, J. Chem. Soc. Rev. 1997, 26, 269-277.
2. (a) Rasmusson, G. H.; Reynolds, G. F.; Steinberg, N. G.; Walton, E.; Patel, G.F.; Liang, T.; Cascieri, M. A.; Cheung, A. H.; Brooks, J. R.; Berman, C. J. Med. Chem. 1986, 29, 2298-2315. (b) Frye, S. V.; Haffner, C. D.; Maloney, P. R.; Mook, R. A.; Jr., Dorsey, G. F.; Jr., Hiner, R. N.; Cribbs, C. M.; Wheeler, T. N.; Ray, J. A.; Andrews, R. C.; Batchelor, K. W.; Bramson, H. N.; Stuart, J. D.; Schweiker, S. L.; Van Arnold, J.; Croom, S.; Bickett, D. M.; Moss, M. L.; Tian, G.; Unwalla, R. J.; Lee, F. W.; Tippin, T. K.; James, M. K.; Long, J. E.; Schuster, S. V. J. Med. Chem. 1994, 37, 2352-2360. (c) Frye, S. V. Current Pharm. Design 1996, 2, 59-84.
3. Pirrung, M. C.; Chen, J.; Rowley, E. G.; McPhail, A. T. J. Am. Chem. Soc. 1993, 115, 7103-7110.
4. (a) Holt, D. A.; Levy, M. A.; Oh, H.-J.; Erb, J. M.; Heaslip, J. I.; Brandt, M.; Lan-Hargest, H.-Y.; Metcalf, B. W. J. Med. Chem. 1990, 33, 943-950. (b) Haffner, C.D. Tetrahedron Lett. 1994, 35, 1349-1353.
5. Lattes, A.; Oliveros, E.; Riviere, M.; Belzecki, C.; Mostowicz, D.; Abramskj, W.; Piccinni-Leopardi, C.; Germain, G.; Meerssche, M. V. J. Am. Chem. Soc. 1982, 104, 3929-3934.
6. (a) Aubé, J.; Wang, Y.; Hammond, M.; Tanol, M.; Takusagawa, F.; Velde, D. V. J. Am. Chem. Soc. 1990, 112, 4879-4891. (b) Aubé, J. Chem. Soc. Rev. 1997, 26, 269-277.
Downloads
Published
2019-06-24
Issue
Section
Regular Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
